<DOC>
	<DOCNO>NCT00427596</DOCNO>
	<brief_summary>This two-part study . Part 1 design find best modified release formulation GW423753 ; Part 2 design use select formulation ( ) Part 1 find food affect way medication process body .</brief_summary>
	<brief_title>A Two-Part Study Determine : Best Medication Formulation Food Effect</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solabegron</mesh_term>
	<criteria>Healthy male &amp; female Part 1 age 1860 Part 2 age 1850 &amp; 6580 Within normal weight range give height Negative urine drug alcohol test Willing follow study procedures Any clinically relevant abnormality identify screen physical examination , clinical laboratory test , 12lead ECG , medical condition circumstance make subject unsuitable participation study base Investigator 's assessment . Subjects either blood pressure measurement &gt; 150/90 mmHg , history coronary disease AND blood pressure &gt; 140/90 mmHg , screen . History drug allergy , , opinion Investigator , contraindicate participation . Regular alcohol consumption average &gt; /7 drinks/week woman &gt; / 14 drinks/week men ( 1 drink = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month first dose study medication . Positive urine drug , alcohol serum pregnancy test screen prior dose study session . Positive hepatitis C antibody , hepatitis B surface antigen HIV screening . Treatment investigational drug within 30 day 5 halflives ( whichever longer ) prior administration study medication . Use prescription nonprescription drug within 7 day 5 halflives ( whichever longer ) prior administration study medication study . By exception , use acetaminophen dose â‰¤ 2 gram per day , use contraceptive ( oral , depot , patch , etc . ) antihypertensive medication permit . Use vitamins herbal/dietary supplement within 7 day prior administration study medication study . Subject unable and/or unwilling adhere Lifestyle Guidelines Subjects donate 500 mL blood plasma within 56 day prior administration study medication . An unwillingness part male volunteer abstain sexual intercourse pregnant lactating woman ; unwillingness use condom another form contraception ( e.g. , IUD , birth control pills take female partner , diaphragm spermicide ) engage sexual intercourse woman could become pregnant time first dose study medication completion followup procedure . Pregnant lactate woman . A pregnancy test perform woman screen prior dose session confirm eligibility . The subject know hypersensitivity idiosyncratic reaction drug chemical relate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>GW427353 oral tablet ,</keyword>
	<keyword>healthy adult subject ,</keyword>
	<keyword>food effect</keyword>
</DOC>